publication date: Dec. 21, 2010

In this issue: 

NCI’s use of Cancer Dialogue for biospecimen network blueprint raises legal, procedural questions.

Plan posted for “public comment” on Dialogue’s Web site; who will respond, Dialogue or NCI? Cost estimate of network significantly reduced.

Also Stillman named director, Cold Spring Harbor, Watson is chancellor.

Pollin Prize honors four pioneers in treatment of childhood leukemia.

December Business & Regulatory Report included in this issue.

The Cancer Letter takes two-week break; next issue Jan. 2.

Download (PDF 505KB)

To access this members-only content, please log in.
Institutional subscribers, please log in with your IP.
If you're not a subscriber why not join today?
To gain access to the members only content click here to subscribe.
You will be given immediate access to premium content on the site.
Click here to join.

Copyright (c) 2020 The Cancer Letter Inc.